High materiality7/10
Opus Genetics price target raised to $16 from $13 at Chardan
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Chardan raises IRD target to $16; current price around $5.67; priceChangeSinceSignal +3.53 indicates momentum.
Target: $16
Posted price: $5.67
Analyst firm: Chardan Capital
Analyst: Andreas Argyrides
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.